• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Additional risk factors in atrial fibrillation patients not receiving warfarin.

作者信息

Wensley S, Keir S, Caine S, Mac Mahon M

机构信息

Department of Medicine for the Elderly, Bristol Royal Infirmary, UK.

出版信息

Age Ageing. 1999 Jul;28(4):355-7. doi: 10.1093/ageing/28.4.355.

DOI:10.1093/ageing/28.4.355
PMID:10459787
Abstract

OBJECTIVE

To study how many elderly inpatients with previously diagnosed atrial fibrillation were not receiving anticoagulant prophylaxis, and the prevalence of additional risk factors in these patients.

METHODS

All new admissions to a department of medicine for the elderly were screened for atrial fibrillation. Additional risk factors were analysed in those with established atrial fibrillation who were not receiving warfarin. Previous hospital admissions, documentation of why prophylaxis was not being used and use of aspirin as an alternative agent were also examined.

RESULTS

56 patients had previously diagnosed atrial fibrillation; 82% were not taking warfarin and 71% of these were not on aspirin either. All patients not taking warfarin had one additional risk factor for stroke and 95% had two or more. Fifty-two percent had attended hospital when atrial fibrillation was present within the previous 3 years and there was nothing documented in their records to explain why anticoagulation had not been used.

CONCLUSIONS

Most elderly inpatients with established atrial fibrillation were not taking warfarin. All had additional risk factors for stroke, which increase the absolute benefit of anticoagulation.

摘要

相似文献

1
Additional risk factors in atrial fibrillation patients not receiving warfarin.
Age Ageing. 1999 Jul;28(4):355-7. doi: 10.1093/ageing/28.4.355.
2
Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals.大学医院心房颤动患者的抗栓治疗现状
Arch Intern Med. 1996 Nov 11;156(20):2311-6.
3
Warfarin versus aspirin in the elderly in primary prophylaxis for atrial fibrillation.华法林与阿司匹林用于老年患者心房颤动一级预防的比较
Age Ageing. 2007 Mar;36(2):117-9. doi: 10.1093/ageing/afl181. Epub 2007 Jan 25.
4
Stroke prevention in elderly patients with atrial fibrillation.老年房颤患者的卒中预防
Singapore Med J. 2002 Apr;43(4):198-201.
5
Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation: the AFASAK 2 study. Atrial Fibrillation Aspirin and Anticoagulation.心房颤动患者华法林与阿司匹林联合治疗期间的出血情况:AFASAK 2研究。心房颤动、阿司匹林与抗凝治疗。
Arch Intern Med. 1999 Jun 28;159(12):1322-8. doi: 10.1001/archinte.159.12.1322.
6
Preventing stroke in patients with atrial fibrillation.预防心房颤动患者的中风。
JAMA. 1999 May 19;281(19):1830-5. doi: 10.1001/jama.281.19.1830.
7
Antithrombotic therapy in atrial fibrillation.心房颤动的抗栓治疗
Can Fam Physician. 1996 Jul;42:1341-5.
8
[Atrial fibrillation and apoplexy--risks and prevention].[心房颤动与中风——风险与预防]
Nord Med. 1996 Jun;111(6):171-5.
9
Anticoagulant prophylaxis against stroke in atrial fibrillation: effectiveness in actual practice.心房颤动患者卒中的抗凝预防:实际应用中的有效性。
CMAJ. 1999 Sep 7;161(5):493-7.
10
Warfarin sodium or aspirin therapy to prevent stroke in nonrheumatic atrial fibrillation. Answered and unanswered questions.华法林钠或阿司匹林疗法预防非风湿性心房颤动患者中风。已解答和未解答的问题。
West J Med. 1995 Aug;163(2):177-9.

引用本文的文献

1
Mortality and rate of stroke or embolism in atrial fibrillation during long-term follow-up in the embolism in left atrial thrombi (ELAT) study.左心房血栓栓塞(ELAT)研究中长期随访期间心房颤动患者的死亡率及中风或栓塞发生率
Clin Cardiol. 2004 Jan;27(1):40-6. doi: 10.1002/clc.4960270111.